Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine
ABSTRACT Plasmalogens are natural glycerophospholipids that account for approximately 15%–20% (mol%) of human tissues' cellular membrane phospholipid composition. They play an important role in lipid membrane organization and function, including acting as endogenous antioxidants. Plasmalogens c...
Saved in:
| Main Authors: | Yu Wu, Yuru Deng, Borislav Angelov, Angelina Angelova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | FASEB BioAdvances |
| Subjects: | |
| Online Access: | https://doi.org/10.1096/fba.2025-00010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of endogenous plasmalogens by genetic ablation of lysoplasmalogenase (Tmem86b) in mice
by: Sudip Paul, et al.
Published: (2025-05-01) -
Bioactive polydopamine nanomedicines-assisted cancer immunotherapy
by: Xionghongcan Zhou, et al.
Published: (2025-06-01) -
Plasmalogens in Innate Immune Cells: From Arachidonate Signaling to Ferroptosis
by: Jesús Balsinde, et al.
Published: (2024-11-01) -
Application of Liquid Chromatography/Tandem Mass Spectrometry for Quantitative Analysis of Plasmalogens in Preadolescent Children—The Hokkaido Study
by: Yifan Chen, et al.
Published: (2025-03-01) -
Dietary Ethanolamine Plasmalogen from Ascidian Alleviates Chronic Hepatic Injury in Mice Treated with Continuous Acetaminophen
by: Ryosuke Sogame, et al.
Published: (2025-05-01)